Sanofi Wins Supreme Court Patent Dispute With Amgen



Justices rule unanimously that Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted



Justices rule unanimously that Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
AmgenAMGNBiopharmaceuticalsBiotechnology ServicesBusinessC&E Executive News FilterC&E Industry News FilterContent Typescorporatecorporate crimeCorporate Crime/Legal ActionCorporate/Industrial NewsCourtcrimeCrime/Legal ActionDisputeEconomyFactiva FiltersFR:SANgeneral newsgovernment policyhealthcareHealthcare/Life Sciencesindustrial newsIndustrial Property RightsIntellectual Property RightsLatestlegal actionlife sciencesnew productsNew Products/ServicespatentpatentsPharmaceuticalspoliticalPolitical/General NewsProductProduct/Service ApprovalsProductsProducts/ServicesRegeneron PharmaceuticalsREGNregulationRegulation/Government PolicySAN.FRSanofiservice approvalsServicesSupremeSYNDwinsWSJ-PRO-WSJ.com
Comments (0)
Add Comment